CED Clinic
  • What to Expect
    • Your First Visit
    • Patient Intake Form
  • Services Offered
    • Telemedicine
    • Pediatric Patients
    • Additional Services
  • Registration Resources
    • Registration Help
    • Next Steps
    • Caregiver Information
    • Cannabis Control Commission
  • Contact
    • Contact the Clinic
    • Social Media Links
    • Review Us!
    • Meet The Team >
      • Meet Dr. Caplan
      • Meet Dr. Exelbert
  • CED Clinic Events
    • Upcoming Events
    • Fireside Chats
    • Dispensary Highlights
    • Past Events
  • Information and FAQ
    • CED Clinic Cannabis Care
    • Cannabis FAQ
    • Recommended Online Resources
    • Patient Stories
    • CED Library
    • Printable Handouts >
      • Cannabis Journal
      • General Cannabis Info
      • Handouts for Illnesses >
        • Infectious Diseases
        • Mental Health
        • Skin Conditions
        • Neurological Disorders
        • Muscular and Skeletal Pain
        • Illnesses of Aging
        • Reproductive Health
        • Gastrointestinal Health
    • Awesome Extras! >
      • Vaporizing Overview
      • Unique Cannabinoids
      • MA Dispensary Map
      • Cannabis for Sleep
      • Topical Cannabis Products
      • Cooking with Cannabis
      • Cannabis Cookbook
  • Video Library
  • Massachusetts Dispensaries
  • Site Map
  • CED Blog
  • Blog
  • Socials
  • CED Clinic Services

CED Blog

Use the search bar above to explore our blog articles! 

Everything You Need to Know About Current Cannabis Laws and Challenges

5/9/2020

0 Comments

 
Regulatory and legislative disparities with cannabis present challenges to P&T committees and health care providers ​
In Summary
​An article has recently been published that gives a summary of current federal and state cannabis laws and highlights the arising regulatory and legislative challenges. Cannabis is still considered a Schedule I drug at the federal level under the Controlled Substances Act but the FDA approval of Edioplex, a cannabidiol (CBD)-based epilepsy medication, has caused CBD to be ruled as a Schedule V drug by the Drug Enforcement Agency. The piece explains the implications of CBD approval, including the Farm Bill passed in 2018 and discusses the intricacies of maneuvering between federal and state drug regulations. Current laws, even at the federal level, show a shift towards the approval of cannabis products but there is still a long way to go. 
The article also highlights and attempts to explain the difficulties that physicians, budtenders,  and pharmacists in prescribing, licensing, and providing cannabis. Some states, not including Massachusetts, require that pharmacists provide cannabis so that they can properly advise patients about the risks and benefits of cannabis use. Massachusetts (MA), like many other states who have legalized medical cannabis, do not require budtenders at dispensaries to possess any prior medical knowledge, meaning that their advice on which strain or product a patient should try can be extremely under-informed and subjective. Patients in states like MA should take care to speak with their licensing physician or nurse practitioner about which cannabinoids or products would likely be best for them. 
The study is available for review or download here:
Download & Review HERE
View more studies like this in the CED Foundation Archive:  http://bit.ly/drcaplan 

​
0 Comments

The Legal Issues Concerning State Medical Cannabis Programs

5/3/2020

0 Comments

 
Emerging public health law and policy issues concerning state medical cannabis programs
In Summary
As the medical cannabis industry grows and local governments continue to legalize medical cannabis use state programs are forced to set standards without the aid of the federal government. State governments are now facing the challenge of attempting to regulate medical cannabis while maintaining the safety of patients and the general public. States now have to regulate labeling with universal warning symbols, child-resistant packaging, advertising restrictions, and pesticide use while also addressing members of the public's concern about the safety of medical cannabis. If cannabis is ever rescheduled in the future so that the federal government can standardize the regulation of cannabis practices across the nation it will be interesting to see how local practices change in accordance. 
​
Despite multiple petitions and new research, the federal government has refused to reschedule cannabis. Cannabis used to be an accepted medication before a few politicians, namely Harry Anslinger began a propaganda campaign, highlighted by the film Reefer Madness (1936), turning the public opinion away from medical cannabis. This was largely thought to be a move to further ostracize minorities, further segregating races as Anslinger connected marijuana to violence to immigrants from Mexico. Cannabis never became medically dangerous in the early 1900s, merely a tool used by politicians to induce public fear and reinforce racist tendencies. In the featured article it was stated that 9 out of 10 Americans support the use of medical marijuana yet cannabis still has yet to be rescheduled and the reasons behind it are unclear but may lead back to the original push to have cannabis outlawed in the first place.
The study is available for review or download here:
Download & Review HERE
View more studies like this in the CED Foundation Archive:  http://bit.ly/drcaplan 
0 Comments

Legalizing Medical and Recreational Cannabis May Decrease Adolescent Use

4/21/2020

1 Comment

 
Association of marijuana laws with teen marijuana use- new estimates from the youth risk behavior surveys
In Summary
 Earlier this July a letter was published providing evidence that adolescent cannabis use may actually decrease post-legalization of medical and recreational cannabis. An analysis of Youth Risk Behavioral Surveys from the past two decades revealed that legalizing medical cannabis had little to no effect on cannabis use among adolescents in 8th and 10th grade but that legalization of recreational cannabis actually led to an overall decrease of adolescent cannabis use across the states. The authors hypothesize that the rate of adolescent use may decrease as illegal drug dealers are replaced by legal, regulated dispensaries. This evidence may prove compelling for the possible rescheduling of cannabis under the federal Controlled Substances Act. 
​
Adolescent substance use, like that of alcohol, has been found to be detrimental to brain development. There have been varying results regarding the effects of adolescent cannabis use on brain development yet some caretakers are given special permission to administer cannabis-based products to children experiencing rare forms of epilepsy or other seizure disorders. Cannabis-based medications may be a more ethical and far less dangerous substance to administer to children so that they aren’t set up for a substance use disorder at a young age.  The research focussed on adolescent cannabis use needs to be conducted for better regulations and to better advise the parents and pediatricians of adolescents who have accidentally consumed cannabis or need a cannabis-based medical intervention.  
The study is available for review or download here:
Download & Review HERE
View more studies like this in the CED Foundation Archive:  http://bit.ly/drcaplan 
1 Comment

    Archives

    June 2022
    December 2021
    November 2021
    October 2021
    September 2021
    July 2021
    June 2021
    May 2021
    April 2021
    March 2021
    February 2021
    January 2021
    December 2020
    November 2020
    October 2020
    September 2020
    August 2020
    July 2020
    May 2020
    April 2020
    March 2020
    February 2020
    January 2020
    December 2019
    July 2019

    Categories

    All
    Adolescent
    Alcohol
    Analgesic
    Antitumor
    Anxiety
    Arthritis
    Athletes
    Australia
    Benzodiazepines
    Bioflavonoids
    Brain
    Breast Cancer
    Canada
    Cancer
    Cannabidiol
    Cannabinoid
    Cannabinoid Receptor 1
    Cannabinoid Receptor 2
    Cannabinoids
    Cannabis
    Cardiovascular
    CB1
    CB2
    CBD
    CBG
    CBN
    CBT
    Cessation
    Cholesterol
    Chronic Pain
    Clinical
    Cognitive
    Cognitive Health
    Colorado
    Consumption
    Coronavirus
    COVID 19
    COVID-19
    Curcumin
    Cytokine-induced Killer Cells
    Decarboxylation
    Dependence
    Diet
    Dispensaries
    Drug Abuse
    ECS
    Edibles
    Endocannabinoid System
    Entourage Effect
    Epilepsy
    Fasciae
    Fatty Acid
    FDA
    Feline
    Female Reproductive System
    Females
    Fibromyalgia
    Flavonoids
    Football
    Gastroenterology
    Growing
    Heart Disease
    Hemp
    History
    Hospitalization
    Hypothermia
    Illicit
    Industry
    Inflammation
    Injury
    Insomnia
    Israel
    Law
    Legalization
    Lung Cancer
    Male
    Marketing
    Massachusetts
    #MDTake
    Medical Cannabis
    Memory
    Men's Health
    Mental Health
    Metabolomics
    Mice
    Microdosing
    Military
    Multiple Myeloma
    Multiple Sclerosis
    Musculoskeletal
    Myofascial Tissue
    Neurodegenerative Conditions
    Neurological
    Neuroprotective Effect
    Neuropsychiatric Disorders
    NFL
    Nicotine
    Non-Cannabis Plant
    Norway
    Obesity
    Olfactory Ciruit
    Opioids
    Pain Relief
    Parkinson's Disease
    Pediatrics
    Pelvic Pain
    Pets
    Physical Activity
    Plant
    Pregnancy
    Prenatal
    Psoriasis
    Psychiatric
    Psychosis
    PTSD
    Public Health
    Recreational Cannabis
    Relaxing
    Respiratory
    Rheumatic Diseases
    Saliva
    Schizophrenia
    Seizures
    Seniors
    Sexual Intercourse
    Skin
    Smell
    Smoking
    Social Supports
    Spain
    Spinal Cord
    Sports
    Substance Abuse
    Suicide
    Synthetic
    Teratological
    Terpenes
    Tetrahydrocannabinol
    THC
    Therapy
    Tobacco
    Trauma
    UV Irradiation
    Vaping
    Veterans
    Women's Health
    Young Adults

    RSS Feed

Home

Need Registration Help?

Services Offered

Dispensaries

Contact the Clinic

Request Appointment
Copyright © 2022
  • What to Expect
    • Your First Visit
    • Patient Intake Form
  • Services Offered
    • Telemedicine
    • Pediatric Patients
    • Additional Services
  • Registration Resources
    • Registration Help
    • Next Steps
    • Caregiver Information
    • Cannabis Control Commission
  • Contact
    • Contact the Clinic
    • Social Media Links
    • Review Us!
    • Meet The Team >
      • Meet Dr. Caplan
      • Meet Dr. Exelbert
  • CED Clinic Events
    • Upcoming Events
    • Fireside Chats
    • Dispensary Highlights
    • Past Events
  • Information and FAQ
    • CED Clinic Cannabis Care
    • Cannabis FAQ
    • Recommended Online Resources
    • Patient Stories
    • CED Library
    • Printable Handouts >
      • Cannabis Journal
      • General Cannabis Info
      • Handouts for Illnesses >
        • Infectious Diseases
        • Mental Health
        • Skin Conditions
        • Neurological Disorders
        • Muscular and Skeletal Pain
        • Illnesses of Aging
        • Reproductive Health
        • Gastrointestinal Health
    • Awesome Extras! >
      • Vaporizing Overview
      • Unique Cannabinoids
      • MA Dispensary Map
      • Cannabis for Sleep
      • Topical Cannabis Products
      • Cooking with Cannabis
      • Cannabis Cookbook
  • Video Library
  • Massachusetts Dispensaries
  • Site Map
  • CED Blog
  • Blog
  • Socials
  • CED Clinic Services